Abuse of 340B program enriches hospitals without helping poor

Some hospitals with relatively wealthy clientele are boosting their profits through the federal 340B drug discount program without passing the savings on to poor patients, writes Peter Pitts, president of the Center for Medicine in the Public Interest and a former FDA official. "Administrators are getting rich off a well-intentioned public program. Too many uninsured and poor patients still don't have access to discounted drugs," he writes.

View Full Article in:

Sun-Sentinel (Fort Lauderdale, Fla.) (tiered subscription model)